A detailed history of Addison Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Addison Advisors LLC holds 75 shares of UTHR stock, worth $26,968. This represents 0.01% of its overall portfolio holdings.

Number of Shares
75
Previous 75 -0.0%
Holding current value
$26,968
Previous $23,000 13.04%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 02, 2021

BUY
$101.87 - $151.79 $7,640 - $11,384
75 New
75 $11,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Addison Advisors LLC Portfolio

Follow Addison Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Addison Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Addison Advisors LLC with notifications on news.